Write your reply by iruleyoulose on ymb: Brain Atrophy reduction...

Write your reply

by iruleyoulose on ymb:

Brain Atrophy reduction or potential increase in brain volume goes beyond dementia

If Prana can use this to prove that PBT2 reduces brain atrophy and helps prevents the onset of brain atrophy for an aging population, you now have potentially one of the biggest drugs on the market.

This would be a preventive medicine like aspirin, where everyone who is aging could take as a preventive therapeutic. The potential market in the US now just expanded to well over 100M potential users. Even at a cost of treatment of $1500 a year, in the US, that could be $150B in sales. It is staggering. Not to mention the potential worldwide usage which could be in Billions.

Even use by 20 million people worldwide as a therapeutic is still a huge market.

If it increases brain volume, you now have a potential treatment for a significant population with brain injury and trauma.

Been saying this for over a year, this is the potential holy grail for a drug and its shareholders